Abstract
Summary
According to our LPI (LP Information) latest study, the global Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Vaccine market. Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccine market.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Key Features:
The report on Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccine market. It may include historical data, market segmentation by Type (e.g., Varicella Vaccine, Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccine industry. This include advancements in Vaccine technology, Vaccine new entrants, Vaccine new investment, and other innovations that are shaping the future of Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccine market.
Market Segmentation:
Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Segmentation by application
For Adult
For Child
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
The research report highlights the growth potential of the global Vaccine market. Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccine market.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
Key Features:
The report on Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccine market. It may include historical data, market segmentation by Type (e.g., Varicella Vaccine, Influenza Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccine industry. This include advancements in Vaccine technology, Vaccine new entrants, Vaccine new investment, and other innovations that are shaping the future of Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccine market.
Market Segmentation:
Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Segmentation by application
For Adult
For Child
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Market Size 2019-2030
2.1.2 Vaccine Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Vaccine Segment by Type
2.2.1 Varicella Vaccine
2.2.2 Influenza Vaccine
2.2.3 Polio Vaccine
2.2.4 Hepatitis A Vaccine
2.2.5 Rabies Vaccine
2.2.6 BCG Vaccine
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Others
2.3 Vaccine Market Size by Type
2.3.1 Vaccine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Vaccine Market Size Market Share by Type (2019-2024)
2.4 Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 Vaccine Market Size by Application
2.5.1 Vaccine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Vaccine Market Size Market Share by Application (2019-2024)
3 Vaccine Market Size by Player
3.1 Vaccine Market Size Market Share by Players
3.1.1 Global Vaccine Revenue by Players (2019-2024)
3.1.2 Global Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Vaccine by Regions
4.1 Vaccine Market Size by Regions (2019-2024)
4.2 Americas Vaccine Market Size Growth (2019-2024)
4.3 APAC Vaccine Market Size Growth (2019-2024)
4.4 Europe Vaccine Market Size Growth (2019-2024)
4.5 Middle East & Africa Vaccine Market Size Growth (2019-2024)
5 Americas
5.1 Americas Vaccine Market Size by Country (2019-2024)
5.2 Americas Vaccine Market Size by Type (2019-2024)
5.3 Americas Vaccine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Market Size by Region (2019-2024)
6.2 APAC Vaccine Market Size by Type (2019-2024)
6.3 APAC Vaccine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccine by Country (2019-2024)
7.2 Europe Vaccine Market Size by Type (2019-2024)
7.3 Europe Vaccine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine by Region (2019-2024)
8.2 Middle East & Africa Vaccine Market Size by Type (2019-2024)
8.3 Middle East & Africa Vaccine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Vaccine Market Forecast
10.1 Global Vaccine Forecast by Regions (2025-2030)
10.1.1 Global Vaccine Forecast by Regions (2025-2030)
10.1.2 Americas Vaccine Forecast
10.1.3 APAC Vaccine Forecast
10.1.4 Europe Vaccine Forecast
10.1.5 Middle East & Africa Vaccine Forecast
10.2 Americas Vaccine Forecast by Country (2025-2030)
10.2.1 United States Vaccine Market Forecast
10.2.2 Canada Vaccine Market Forecast
10.2.3 Mexico Vaccine Market Forecast
10.2.4 Brazil Vaccine Market Forecast
10.3 APAC Vaccine Forecast by Region (2025-2030)
10.3.1 China Vaccine Market Forecast
10.3.2 Japan Vaccine Market Forecast
10.3.3 Korea Vaccine Market Forecast
10.3.4 Southeast Asia Vaccine Market Forecast
10.3.5 India Vaccine Market Forecast
10.3.6 Australia Vaccine Market Forecast
10.4 Europe Vaccine Forecast by Country (2025-2030)
10.4.1 Germany Vaccine Market Forecast
10.4.2 France Vaccine Market Forecast
10.4.3 UK Vaccine Market Forecast
10.4.4 Italy Vaccine Market Forecast
10.4.5 Russia Vaccine Market Forecast
10.5 Middle East & Africa Vaccine Forecast by Region (2025-2030)
10.5.1 Egypt Vaccine Market Forecast
10.5.2 South Africa Vaccine Market Forecast
10.5.3 Israel Vaccine Market Forecast
10.5.4 Turkey Vaccine Market Forecast
10.5.5 GCC Countries Vaccine Market Forecast
10.6 Global Vaccine Forecast by Type (2025-2030)
10.7 Global Vaccine Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Vaccine Product Offered
11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech Vaccine Product Offered
11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Information
11.3.2 Boehringer-Ingelheim Vaccine Product Offered
11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer-Ingelheim Main Business Overview
11.3.5 Boehringer-Ingelheim Latest Developments
11.4 CCBIO
11.4.1 CCBIO Company Information
11.4.2 CCBIO Vaccine Product Offered
11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 CCBIO Main Business Overview
11.4.5 CCBIO Latest Developments
11.5 CSL
11.5.1 CSL Company Information
11.5.2 CSL Vaccine Product Offered
11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 CSL Main Business Overview
11.5.5 CSL Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Vaccine Product Offered
11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Elanco
11.7.1 Elanco Company Information
11.7.2 Elanco Vaccine Product Offered
11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Elanco Main Business Overview
11.7.5 Elanco Latest Developments
11.8 GSK
11.8.1 GSK Company Information
11.8.2 GSK Vaccine Product Offered
11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 GSK Main Business Overview
11.8.5 GSK Latest Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Information
11.9.2 Hulan Bio Vaccine Product Offered
11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Hulan Bio Main Business Overview
11.9.5 Hulan Bio Latest Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Information
11.10.2 Indian Immunologicals Vaccine Product Offered
11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Indian Immunologicals Main Business Overview
11.10.5 Indian Immunologicals Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine Product Offered
11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Information
11.12.2 Minhai Biotechnology Vaccine Product Offered
11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Minhai Biotechnology Main Business Overview
11.12.5 Minhai Biotechnology Latest Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
11.13.5 Mitsubishi Tanabe Pharma Latest Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Information
11.14.2 Moderna Therapeutics Vaccine Product Offered
11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Moderna Therapeutics Main Business Overview
11.14.5 Moderna Therapeutics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Vaccine Product Offered
11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Information
11.16.2 Plumbline Life Sciences Vaccine Product Offered
11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Plumbline Life Sciences Main Business Overview
11.16.5 Plumbline Life Sciences Latest Developments
11.17 Sanofi
11.17.1 Sanofi Company Information
11.17.2 Sanofi Vaccine Product Offered
11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sanofi Main Business Overview
11.17.5 Sanofi Latest Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Information
11.18.2 Translate Bio Vaccine Product Offered
11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Translate Bio Main Business Overview
11.18.5 Translate Bio Latest Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Information
11.19.2 Walvax Biotechnology Vaccine Product Offered
11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Walvax Biotechnology Main Business Overview
11.19.5 Walvax Biotechnology Latest Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Information
11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Wuhan Institute of Biological Products Main Business Overview
11.20.5 Wuhan Institute of Biological Products Latest Developments
11.21 Zoties
11.21.1 Zoties Company Information
11.21.2 Zoties Vaccine Product Offered
11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Zoties Main Business Overview
11.21.5 Zoties Latest Developments
12 Research Findings and Conclusion